Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paliperidone palmitate safety and tolerability in Chinese patients with schizophrenia
CTR20132564Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Dec 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of paliperidone palmitate in schizophrenia, sponsored by Janssen Pharmaceutical. Started Dec 2014; status: completed.
02
Drugs
paliperidone palmitate
03
Conditions
schizophrenia
Beyond the preview
Go deeper on CTR20132564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132564.